Roundtable: Focus on Non-Hodgkin Lymphoma

A roundtable discussion, moderated by Kami J. Maddocks, MD, of the James Cancer Hospital, Ohio State University Comprehensive Cancer Center, focused on treatment options for diffuse large B-cell lymphoma and follicular lymphoma, including novel emerging therapies and treatment sequencing considerations. Dr. Maddocks was joined by a panel that included Pierluigi Porcu, MD; Pamela Blair Allen, MD, MSc; and Jonathan W. Friedberg, MD.

Advertisement
Advertisement
Greg Nowakowski, MDAggressive B-Cell Lymphoma | January 21, 2025
The panel discussed novel targeted combinations in CNS lymphoma, such as BTK inhibitors in combination with IRAK inhibitors.
Greg Nowakowski, MDAggressive B-Cell Lymphoma | January 21, 2025
The panel, moderated by Grzegorz Nowakowski, MD, discussed how to manage methotrexate toxicity in CNS lymphoma.
Greg Nowakowski, MDAggressive B-Cell Lymphoma | December 5, 2024
The panel, moderated by Grzegorz Nowakowski, MD, also assessed the feasibility of a CSF biomarker for this disease.
Greg Nowakowski, MDAggressive B-Cell Lymphoma | December 5, 2024
Transplantation and radiation are prominent topics in this expert panel segment, moderated by Grzegorz Nowakowski, MD.
Greg Nowakowski, MDAggressive B-Cell Lymphoma | December 2, 2024
The panel, moderated by Grzegorz Nowakowski, MD, discussed options like lenalidomide, BTK inhibitors, and clinical trials.
Greg Nowakowski, MDAggressive B-Cell Lymphoma | November 25, 2024
Grzegorz Nowakowski, MD, asks an expert panel about their approaches and special issues they encounter in first-line care.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
The panel discusses new targets for DLBCL and FL and shares what excites them about the future for these diseases.
Blood Cancers Today Staff WritersAggressive B-Cell Lymphoma | February 15, 2024
The panel discusses regulatory hurdles and patient access considerations for non-Hodgkin lymphoma therapies.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
The panel discusses treatment sequencing after CAR-T or transplant and the role bispecifics and other regimens may play.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
The panel discusses combination therapy options for patients with DLBCL and FL.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
The panel discusses novel treatment options for FL, including bispecifics, CAR-Ts, monoclonal antibodies, and more.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
The panel talks about novel therapies for DLBCL, including the timing and sequencing for such treatments and more.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
The panel discusses barriers to improving treatment options for patients with DLBCL and follicular lymphoma.
Blood Cancers Today Staff WritersVideo Insights | April 19, 2023
A panel discusses the unmet needs and emerging therapeutic areas for DLBCL and follicular lymphoma.
Advertisement
Advertisement